A Test of Neural Inertia in Humans With Xenon
Sponsor: University of Pennsylvania
This PHASE2 trial investigates Neurocognitive Dysfunction and is currently completed. University of Pennsylvania leads this study, which shows 14 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Sep 2022 — Jul 2024 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Apr 2021 — Sep 2022 [monthly]
Active Not Recruiting PHASE2
Status: Suspended → Active Not Recruiting
-
Jan 2021 — Apr 2021 [monthly]
Suspended PHASE2
▶ Show 9 earlier versions
-
Aug 2020 — Jan 2021 [monthly]
Suspended PHASE2
-
May 2020 — Aug 2020 [monthly]
Suspended PHASE2
Status: Recruiting → Suspended
-
Aug 2019 — May 2020 [monthly]
Recruiting PHASE2
-
Jun 2019 — Aug 2019 [monthly]
Recruiting PHASE2
-
Dec 2018 — Jun 2019 [monthly]
Recruiting PHASE2
-
Jun 2018 — Dec 2018 [monthly]
Recruiting PHASE2
-
Feb 2018 — Jun 2018 [monthly]
Recruiting PHASE2
-
Feb 2017 — Feb 2018 [monthly]
Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2
First recorded
Apr 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .